| Avantara Huron | |
| 1345 Michigan Avenue Sw, Huron, South Dakota 57350 | |
| (605) 352-8471 | |
| Name | Avantara Huron |
|---|---|
| Location | 1345 Michigan Avenue Sw, Huron, South Dakota |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 68 |
| Occupancy Rate | 86.32% |
| Medicare ID (CCN) | 435020 |
| Legal Business Name | Huron Sd Skilled Nursing Facility, Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1376190371 |
| Organization Name | HURON SD SKILLED NURSING FACILITY LLC |
| Address | 1345 Michigan Ave Sw, Huron, SD 57350 |
| Phone Number | 605-352-7600 |
News Archive
Mersana Therapeutics, a platform-based cancer therapeutics company, announced today that a review of the Company's lead compound, XMT-1001, will appear in the November 12, 2009 special issue of Advanced Drug Delivery Reviews on Polymer Therapeutics: Clinical Applications and Challenges for Development.
Joint injury can result in irreversible damage of cartilage which, despite treatment and surgery, often eventually leads to osteoarthritis (OA) in later life. New research published in BioMed Central's open access journal Arthritis Research & Therapy demonstrates that short term treatment of damaged cartilage with glucocorticoids can reduce long term degenerative changes and may provide hope for prevention of OA after injury.
Brookdale Senior Living Inc. announced today the sale of an aggregate of 10,000,000 shares of its common stock by certain affiliates of Fortress Investment Group LLC. The Company will not sell any shares in the offering and will not receive any of the proceeds from the offering. Subject to customary conditions, the offering is expected to close on May 17, 2010.
Patient eligibility for opioids is seriously restricted in some countries, with the highest rate of limited access to palliative care found in the Middle East, followed by Latin America and the Caribbean and Asia. Data are revealed by the ESMO Global Opioid Policy Initiative (GOPI) which identifies barriers to the availability and accessibility of essential pain relieving medication worldwide.
Mobile health technology can be beneficial in encouraging lifestyle behavior changes and medication adherence among adults ages 60 and older with existing heart disease, yet more research is needed to determine what methods are the most effective.
› Verified 8 days ago
| NPI Number | 1700969490 |
| Organization Name | HEALTH QUEST INC |
| Doing Business As | SUNQUEST HEALTHCARE CENTER |
| Address | 1345 Michigan Ave Sw, Huron, SD 57350 |
| Phone Number | 605-352-8471 |
News Archive
Mersana Therapeutics, a platform-based cancer therapeutics company, announced today that a review of the Company's lead compound, XMT-1001, will appear in the November 12, 2009 special issue of Advanced Drug Delivery Reviews on Polymer Therapeutics: Clinical Applications and Challenges for Development.
Joint injury can result in irreversible damage of cartilage which, despite treatment and surgery, often eventually leads to osteoarthritis (OA) in later life. New research published in BioMed Central's open access journal Arthritis Research & Therapy demonstrates that short term treatment of damaged cartilage with glucocorticoids can reduce long term degenerative changes and may provide hope for prevention of OA after injury.
Brookdale Senior Living Inc. announced today the sale of an aggregate of 10,000,000 shares of its common stock by certain affiliates of Fortress Investment Group LLC. The Company will not sell any shares in the offering and will not receive any of the proceeds from the offering. Subject to customary conditions, the offering is expected to close on May 17, 2010.
Patient eligibility for opioids is seriously restricted in some countries, with the highest rate of limited access to palliative care found in the Middle East, followed by Latin America and the Caribbean and Asia. Data are revealed by the ESMO Global Opioid Policy Initiative (GOPI) which identifies barriers to the availability and accessibility of essential pain relieving medication worldwide.
Mobile health technology can be beneficial in encouraging lifestyle behavior changes and medication adherence among adults ages 60 and older with existing heart disease, yet more research is needed to determine what methods are the most effective.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Mersana Therapeutics, a platform-based cancer therapeutics company, announced today that a review of the Company's lead compound, XMT-1001, will appear in the November 12, 2009 special issue of Advanced Drug Delivery Reviews on Polymer Therapeutics: Clinical Applications and Challenges for Development.
Joint injury can result in irreversible damage of cartilage which, despite treatment and surgery, often eventually leads to osteoarthritis (OA) in later life. New research published in BioMed Central's open access journal Arthritis Research & Therapy demonstrates that short term treatment of damaged cartilage with glucocorticoids can reduce long term degenerative changes and may provide hope for prevention of OA after injury.
Brookdale Senior Living Inc. announced today the sale of an aggregate of 10,000,000 shares of its common stock by certain affiliates of Fortress Investment Group LLC. The Company will not sell any shares in the offering and will not receive any of the proceeds from the offering. Subject to customary conditions, the offering is expected to close on May 17, 2010.
Patient eligibility for opioids is seriously restricted in some countries, with the highest rate of limited access to palliative care found in the Middle East, followed by Latin America and the Caribbean and Asia. Data are revealed by the ESMO Global Opioid Policy Initiative (GOPI) which identifies barriers to the availability and accessibility of essential pain relieving medication worldwide.
Mobile health technology can be beneficial in encouraging lifestyle behavior changes and medication adherence among adults ages 60 and older with existing heart disease, yet more research is needed to determine what methods are the most effective.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 16.93 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.07 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 37.07 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.62 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4.91 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.53 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.35 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 21.29 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 96.7 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 18.89 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 16.92 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 5.37 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 90.4 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 75.92 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 96.14 | 82.93 |
News Archive
Mersana Therapeutics, a platform-based cancer therapeutics company, announced today that a review of the Company's lead compound, XMT-1001, will appear in the November 12, 2009 special issue of Advanced Drug Delivery Reviews on Polymer Therapeutics: Clinical Applications and Challenges for Development.
Joint injury can result in irreversible damage of cartilage which, despite treatment and surgery, often eventually leads to osteoarthritis (OA) in later life. New research published in BioMed Central's open access journal Arthritis Research & Therapy demonstrates that short term treatment of damaged cartilage with glucocorticoids can reduce long term degenerative changes and may provide hope for prevention of OA after injury.
Brookdale Senior Living Inc. announced today the sale of an aggregate of 10,000,000 shares of its common stock by certain affiliates of Fortress Investment Group LLC. The Company will not sell any shares in the offering and will not receive any of the proceeds from the offering. Subject to customary conditions, the offering is expected to close on May 17, 2010.
Patient eligibility for opioids is seriously restricted in some countries, with the highest rate of limited access to palliative care found in the Middle East, followed by Latin America and the Caribbean and Asia. Data are revealed by the ESMO Global Opioid Policy Initiative (GOPI) which identifies barriers to the availability and accessibility of essential pain relieving medication worldwide.
Mobile health technology can be beneficial in encouraging lifestyle behavior changes and medication adherence among adults ages 60 and older with existing heart disease, yet more research is needed to determine what methods are the most effective.
› Verified 8 days ago